GO:0006685 sphingomyelin catabolic process: Sphingolipid Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006685 (sphingomyelin catabolic process) describes the enzymatic breakdown of sphingomyelin into ceramide and phosphorylcholine, a central reaction of sphingolipid metabolism.
• Sphingomyelinases (acid, neutral and alkaline) are the principal enzymes that execute this catabolic process, and their activity is compartment- and pH-dependent.
• The ceramide generated by sphingomyelin catabolism is a bioactive lipid that organizes membrane domains and influences signaling, membrane fluidity and stress responses.
• Altered sphingomyelin catabolism has been linked to cancer chemoresistance, neurodegeneration such as Parkinson's disease, and lysosomal lipid storage disorders.
• Sphingomyelin and its catabolic products contribute to membrane order and cholesterol-dependent trafficking, making this pathway relevant to membrane biology.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models enable causal testing of sphingomyelin catabolic genes in disease-relevant cell systems.
Description
Sphingomyelin catabolic process (GO:0006685) is the set of chemical reactions and pathways that result in the breakdown of sphingomyelin, defined as N-acyl-4-sphingenyl-1-O-phosphorylcholine. This process is a core arm of sphingolipid turnover and is executed mainly by sphingomyelinases, which hydrolyze sphingomyelin to release ceramide and phosphorylcholine. Because both the substrate and the products are bioactive membrane lipids, the catabolic process sits at the intersection of membrane structure, lipid signaling and cellular stress responses. For researchers, GO:0006685 matters because the balance between sphingomyelin and ceramide influences membrane fluidity, domain organization and signal transduction. Ceramide produced through this pathway can organize ceramide-enriched membrane domains and modulate receptor signaling and stress transmission between cells. Conversely, sphingomyelin itself contributes to membrane order and cholesterol-dependent trafficking, so its catabolism is tightly connected to broader lipid homeostasis. Dysregulation of sphingomyelin catabolism has been associated with cancer biology, including chemoresistance, and with neurodegenerative conditions such as Parkinson's disease. This makes the pathway a tractable target for functional genomics, lipidomics and CRISPR-based perturbation studies in disease-relevant cell models.
sphingomyelin catabolic process At A Glance
| GO ID | GO:0006685 |
|---|---|
| GO term | sphingomyelin catabolic process |
| Ontology | biological_process |
| Synonym | sphingomyelin breakdown; sphingomyelin catabolism; sphingomyelin degradation |
| Definition | The chemical reactions and pathways resulting in the breakdown of sphingomyelin, N-acyl-4-sphingenyl-1-O-phosphorylcholine. |
| Major function | Hydrolytic breakdown of sphingomyelin to ceramide and phosphorylcholine, contributing to sphingolipid turnover and lipid signaling. |
| Key enzymes | Sphingomyelinases, including acid, neutral and alkaline forms. |
| Key products | Ceramide and phosphorylcholine. |
| Cellular context | Membrane-associated process influenced by membrane order, cholesterol and lipid trafficking. |
What Is GO:0006685?
In practical terms, GO:0006685 describes the enzymatic conversion of sphingomyelin into ceramide and phosphorylcholine, together with the associated catabolic steps that remove sphingomyelin from membranes. The process is defined by the breakdown of the sphingomyelin molecule, an N-acyl-4-sphingenyl-1-O-phosphorylcholine, and is synonymous with sphingomyelin breakdown, catabolism or degradation. It is a biological process rather than a single molecular function, because it encompasses the coordinated action of enzymes, membrane environments and regulatory inputs that together reduce sphingomyelin levels and generate downstream lipid products.
Why Is sphingomyelin catabolic process Important in Cell Biology?
Sphingomyelin catabolic process is important because it controls the balance between a structural membrane phospholipid and the bioactive lipid ceramide, thereby influencing membrane organization, signaling and cell fate. Ceramide generated by this pathway can alter membrane fluidity and participate in intercellular stress transmission, while sphingomyelin levels affect cholesterol-dependent trafficking and membrane order. Because perturbations in this balance are observed in cancer chemoresistance and in neurodegenerative disease contexts such as Parkinson's disease, the pathway is a meaningful focus for mechanistic and translational research.
• Provides ceramide, a bioactive lipid that organizes membrane domains and modulates signaling.
• Regulates membrane fluidity and contributes to cell-to-cell stress transmission.
• Links sphingomyelin turnover to cholesterol-dependent trafficking and lipid balance.
• Contributes to sphingolipid homeostasis and membrane structural integrity.
• Has been implicated in cancer cell chemoresistance through lipid balance changes.
• Is relevant to Parkinson's disease through the multiple roles of sphingomyelin.
• Serves as a target for functional studies using sphingomyelinase perturbation.
• Can be interrogated with lipidomics and CRISPR models to test causal roles.
• Connects lysosomal and membrane-associated catabolic routes to cellular stress responses.
• Offers a tractable pathway for therapeutic hypothesis testing in lipid-driven disease.
What Happens During sphingomyelin catabolic process?
Substrate recognition and membrane context
In simple terms: The enzyme must find sphingomyelin in the membrane before it can cut it.
Sphingomyelin catabolism begins with the availability of sphingomyelin as a substrate within membranes, where its distribution and local lipid environment influence access by catabolic enzymes. Sphingomyelin contributes to membrane order and interacts with cholesterol, so the physical state of the membrane helps determine how readily the catabolic process proceeds. Ceramide-enriched domains can form as products accumulate, further shaping the membrane environment in which catabolism occurs.
Hydrolysis by sphingomyelinases
In simple terms: Sphingomyelinases are the scissors that cut sphingomyelin into two pieces.
The central catalytic step of GO:0006685 is the hydrolysis of sphingomyelin by sphingomyelinases, releasing ceramide and phosphorylcholine. Different sphingomyelinase activities, including acid and neutral forms, have been described and are distinguished by their pH optima and subcellular contexts. This enzymatic step is the defining reaction of the catabolic process and connects sphingomyelin levels to the generation of ceramide.
Generation of ceramide and downstream effects
In simple terms: The cut releases ceramide, which is a signal molecule, not just a building block.
Ceramide produced by sphingomyelin catabolism can organize ceramide-enriched membrane domains and influence membrane fluidity. Through these membrane effects, ceramide participates in signaling and in the transmission of stress between cells. Thus, the catabolic process is not merely degradative; it generates a lipid second messenger with structural and signaling roles.
Coupling to lipid balance and trafficking
In simple terms: Breaking down sphingomyelin is tied to how cells move and balance other lipids.
Sphingomyelin catabolism is embedded in broader lipid homeostasis, including cholesterol-dependent trafficking and sphingolipid synthesis pathways. Changes in cholesterol status can activate trafficking-coupled sphingolipid synthesis, illustrating the interdependence of these lipid systems. Because sphingomyelin has multiple biological functions, its catabolism is coordinated with membrane and lipid transport processes rather than occurring in isolation.
Relevance to cellular stress and disease states
In simple terms: When this breakdown goes wrong, cells can become stressed or resistant to therapy.
Ceramide generated through sphingomyelin catabolism has been linked to endoplasmic reticulum stress transmission between cells via membrane fluidity changes. Lipid balance, including sphingomyelin metabolism, has been associated with chemoresistance in cancer cells. In neurodegeneration, sphingomyelin and its catabolic pathway have been discussed in the context of Parkinson's disease.
Key Genes Involved in GO:0006685 sphingomyelin catabolic process
The genes and enzymes most directly associated with GO:0006685 are the sphingomyelinases and related lipid-handling proteins that determine sphingomyelin turnover and ceramide generation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SMPD1 | Acid sphingomyelinase that hydrolyzes sphingomyelin to ceramide | Central enzyme for lysosomal sphingomyelin catabolism and lipid storage disease models |
| SMPD2 | Neutral sphingomyelinase family member | Used to study pH-neutral sphingomyelin breakdown and membrane signaling |
| SMPD3 | Neutral sphingomyelinase involved in membrane lipid turnover | Relevant to ceramide generation and membrane domain studies |
| SMPD4 | Neutral sphingomyelinase family member | Candidate for functional knockout studies of sphingomyelin catabolism |
| SMPD5 | Sphingomyelinase-like enzyme | Explored in lipid catabolism and membrane biology |
| ASAH1 | Acid ceramidase acting downstream of ceramide generation | Links sphingomyelin catabolism to ceramide clearance and sphingolipid homeostasis |
| CERS1 | Ceramide synthase contributing to ceramide balance | Helps interpret how catabolic ceramide is balanced by synthesis |
| CERS2 | Ceramide synthase involved in very-long-chain ceramides | Relevant to membrane lipid composition studies |
| UGCG | Glucosylceramide synthase using ceramide as substrate | Connects catabolic ceramide to glycosphingolipid pathways |
| SPTLC1 | Serine palmitoyltransferase subunit for sphingolipid synthesis | Provides context for sphingolipid balance with catabolism |
| SPTLC2 | Serine palmitoyltransferase subunit | Used in studies of sphingolipid synthesis versus breakdown |
| NPC1 | Cholesterol and lipid trafficking protein | Links cholesterol trafficking to sphingolipid balance |
| NPC2 | Lysosomal lipid transfer protein | Relevant to lysosomal lipid handling and catabolism |
| ABCA1 | Cholesterol and phospholipid transporter | Connects membrane lipid efflux to sphingomyelin biology |
| SCARB1 | Scavenger receptor involved in lipid uptake | Used in lipid balance and membrane trafficking studies |
| TFEB | Transcription factor regulating lysosomal and lipid genes | Potential regulator of catabolic and lysosomal lipid programs |
| LAMP1 | Lysosomal membrane marker | Used to localize acid sphingomyelinase catabolic activity |
How Is sphingomyelin catabolic process Regulated?
Sphingomyelin catabolic process is regulated at multiple levels, including enzyme localization, pH-dependent activity of acid versus neutral sphingomyelinases, and the membrane lipid environment. Because sphingomyelin interacts with cholesterol and contributes to membrane order, changes in cholesterol status and trafficking can indirectly influence sphingolipid metabolism. Product ceramide can further modify membrane fluidity and domain organization, creating feedback on the catabolic process and its signaling outputs. In disease contexts such as cancer, lipid balance shifts have been associated with chemoresistance, suggesting that catabolic flux is integrated with stress and survival programs.
sphingomyelin catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMPD1 | Lysosomal sphingomyelin catabolism and lipid storage biology | Knockout and point-mutation cell lines with lipidomics readouts |
| SMPD2 | Neutral sphingomyelinase signaling and membrane domains | Overexpression and knockout models in cancer cell lines |
| SMPD3 | Ceramide generation and membrane lipid turnover | Knock-in tagged models for localization studies |
| NPC1 | Cholesterol and sphingolipid trafficking | Knockout models to test lipid balance interactions |
| ASAH1 | Ceramide clearance and sphingolipid homeostasis | Point-mutation models to dissect catabolic flux |
Sphingomyelin catabolism in cancer and chemoresistance
Lipid balance, including sphingomyelin metabolism, has been associated with chemoresistance in cancer cells. Because sphingomyelin catabolism generates ceramide, a lipid implicated in membrane domain organization and stress signaling, changes in this pathway may influence how tumor cells respond to therapy. Experimental models that perturb sphingomyelinase genes can help test whether catabolic flux causally affects drug sensitivity.
Neurodegeneration and Parkinson's disease
Sphingomyelin has multiple roles in Parkinson's disease, and its catabolic pathway is part of the broader sphingolipid biology relevant to neurodegeneration. Ceramide generated by sphingomyelin breakdown can affect membrane fluidity and intercellular stress transmission, processes that are relevant to neuronal stress responses. Studying sphingomyelin catabolic genes in neuronal models may clarify how lipid imbalance contributes to disease phenotypes.
Lysosomal lipid storage and membrane trafficking disorders
Acid sphingomyelinase is a lysosomal enzyme, so defects in sphingomyelin catabolism intersect with lysosomal lipid storage and trafficking biology. Cholesterol and lipid trafficking proteins such as NPC1 and NPC2 are connected to sphingolipid balance, linking catabolic defects to membrane transport pathways. These connections make sphingomyelin catabolism relevant to disorders of lipid handling and lysosomal function.
Membrane stress and intercellular signaling
Ceramide produced by sphingomyelin catabolism can mediate cell-to-cell endoplasmic reticulum stress transmission by modulating membrane fluidity. Ceramide-enriched membrane domains provide a structural platform for signaling events. Thus, dysregulated sphingomyelin catabolism may contribute to stress-related pathology through membrane-mediated mechanisms.
From sphingomyelin catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a sphingomyelinase gene required for sphingomyelin breakdown? | CRISPR knockout cell line with lipidomics |
| Does a specific catalytic residue control enzyme activity? | Point-mutation knock-in of the catalytic site |
| Where does the enzyme localize in cells? | Tagged knock-in with fluorescent or epitope tag |
| Does increased catabolic flux change ceramide signaling? | Overexpression of sphingomyelinase |
| Does catabolic flux affect drug sensitivity? | Knockout or overexpression in chemoresistant cancer models |
| Does lipid trafficking influence catabolism? | Knockout of cholesterol trafficking genes with lipid profiling |
How to Study the sphingomyelin catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Sphingomyelin and ceramide species levels | Quantifying catabolic flux after gene perturbation |
| Sphingomyelinase activity assay | Enzymatic hydrolysis of sphingomyelin | Comparing acid versus neutral activity |
| Fluorescence microscopy | Membrane domain organization and enzyme localization | Studying ceramide-enriched domains |
| RNA-seq | Transcriptional changes after perturbation | Identifying compensatory lipid pathways |
| CRISPR library screening | Gene requirements for catabolic phenotypes | Discovering regulators of sphingomyelin catabolism |
| Western blot | Protein expression of sphingomyelinases | Validating knockout or overexpression models |
| Membrane fluidity assays | Physical properties of membranes | Linking ceramide to stress transmission |
| Co-localization imaging | Overlap of enzymes with organelle markers | Confirming lysosomal or membrane localization |
Lipidomics and sphingolipid profiling
Mass spectrometry-based lipidomics can quantify sphingomyelin and ceramide species to measure catabolic flux and pathway balance. Such profiling is essential for linking genetic perturbation to changes in lipid products.
Enzyme activity assays
Sphingomyelinase activity assays distinguish acid and neutral activities based on pH and substrate conditions. These assays provide direct functional readouts of GO:0006685 in cell lysates or fractions.
Membrane and imaging approaches
Imaging of membrane domains and fluidity can reveal how ceramide produced by sphingomyelin catabolism alters membrane organization. Tagged knock-in models allow localization of catabolic enzymes to specific compartments.
Transcriptomics and functional genomics
RNA-seq and CRISPR library screening can identify genes that regulate sphingomyelin catabolism or buffer its loss. These approaches connect the pathway to broader lipid and stress networks.
How CRISPR Can Be Used to Study GO:0006685 sphingomyelin catabolic process
Knockout
CRISPR knockout of sphingomyelinase genes such as SMPD1, SMPD2 or SMPD3 can test whether a specific enzyme is required for sphingomyelin catabolic process. Knockout clones are typically validated by activity assays and lipidomics to confirm loss of catabolic flux.
Point Mutation
Point-mutation models can dissect catalytic residues or regulatory sites within sphingomyelinases, allowing separation of enzymatic activity from scaffolding functions. Such models are useful when complete knockout causes confounding lipid remodeling.
Knock-in
Tagged knock-in of endogenous sphingomyelinase loci enables localization and interaction studies under native expression control. This is valuable for determining where sphingomyelin catabolism occurs within the cell.
Overexpression
Overexpression of sphingomyelinases can increase ceramide generation and reveal downstream effects on membrane fluidity, signaling and stress responses. Overexpression models are also used to test whether increased catabolic flux alters drug sensitivity in cancer cells.
How EDITGENE Supports sphingomyelin catabolic process Research
Researchers studying sphingomyelin catabolic process-related genes often need to determine whether a candidate gene is causally involved in sphingomyelin breakdown, ceramide generation or disease-relevant lipid phenotypes. Rigorous causal testing requires well-controlled genetic models that isolate the gene of interest from compensatory lipid remodeling. EDITGENE provides such models to support mechanistic and translational studies of GO:0006685.
Contact EDITGENE today to design your custom CRISPR model for sphingomyelin catabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SMPD1 Knockout HEK293 Cell Line | EDJ-KQ1740 | Human | 6609 | Details Get a Quote |
| PSAP Knockout HEK293 Cell Line | EDJ-KQ2673 | Human | 5660 | Details Get a Quote |
| SMPD3 Knockout HEK293 Cell Line | EDJ-KQ3537 | Human | 55512 | Details Get a Quote |
| SMPDL3A Knockout HEK293 Cell Line | EDJ-KQ6577 | Human | 10924 | Details Get a Quote |
| SMPDL3B Knockout HEK293 Cell Line | EDJ-KQ8749 | Human | 27293 | Details Get a Quote |
| SMPD4 Knockout HEK293 Cell Line | EDJ-KQ15403 | Human | 55627 | Details Get a Quote |
| ASAH1 Knockout HEK293 Cell Line | EDJ-KQ17855 | Human | 427 | Details Get a Quote |
| SMPDL3A Knockout A-549 Cell Line | EDJ-KQ32164 | Human | 10924 | Details Get a Quote |
| SMPDL3A Knockout HCT 116 Cell Line | EDJ-KQ32165 | Human | 10924 | Details Get a Quote |
| SMPDL3A Knockout HeLa Cell Line | EDJ-KQ32166 | Human | 10924 | Details Get a Quote |
| SMPDL3B Knockout A-549 Cell Line | EDJ-KQ34995 | Human | 27293 | Details Get a Quote |
| SMPDL3B Knockout HCT 116 Cell Line | EDJ-KQ34996 | Human | 27293 | Details Get a Quote |
| SMPD4 Knockout A-549 Cell Line | EDJ-KQ46168 | Human | 55627 | Details Get a Quote |
| SMPD4 Knockout HeLa Cell Line | EDJ-KQ46170 | Human | 55627 | Details Get a Quote |
| SMPD1 Knockout A-549 Cell Line | EDJ-KQ21590 | Human | 6609 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About sphingomyelin catabolic process
What is GO:0006685 sphingomyelin catabolic process?
GO:0006685 is the biological process describing the chemical reactions and pathways that break down sphingomyelin into products including ceramide and phosphorylcholine.
What enzymes carry out sphingomyelin catabolic process?
Sphingomyelinases, including acid and neutral forms, are the principal enzymes that hydrolyze sphingomyelin.
What genes are involved in sphingomyelin catabolic process?
Genes such as SMPD1, SMPD2, SMPD3 and related lipid-handling genes contribute to sphingomyelin breakdown and ceramide balance.
What is the product of sphingomyelin catabolism?
The main products are ceramide and phosphorylcholine, with ceramide acting as a bioactive lipid.
Why is sphingomyelin catabolic process important in cancer?
Lipid balance changes, including sphingomyelin metabolism, have been associated with chemoresistance in cancer cells.
Is sphingomyelin catabolism linked to Parkinson's disease?
Sphingomyelin has multiple roles in Parkinson's disease, and its catabolic pathway is part of the relevant sphingolipid biology.
How does ceramide affect membranes?
Ceramide can organize ceramide-enriched membrane domains and modulate membrane fluidity and signaling.
How can researchers study sphingomyelin catabolic process?
Lipidomics, sphingomyelinase activity assays, imaging and CRISPR perturbation models are commonly used.
What CRISPR models are useful for studying this pathway?
Knockout, point-mutation, knock-in and overexpression models of sphingomyelinase genes are all useful for causal studies.
Does cholesterol affect sphingomyelin catabolism?
Cholesterol status and trafficking influence sphingolipid metabolism and membrane order, linking cholesterol to sphingomyelin biology.
Conclusion
GO:0006685 sphingomyelin catabolic process defines the enzymatic breakdown of sphingomyelin into ceramide and phosphorylcholine, a reaction that shapes membrane organization and lipid signaling. Its products and regulatory connections place it at the center of membrane biology, stress responses and disease-relevant lipid balance. CRISPR-based knockout, point-mutation, knock-in and overexpression models provide the causal tools needed to interrogate this pathway in cancer, neurodegeneration and lipid trafficking contexts.
References
- 1. Huo Y et al.. 2025. Ceramide mediates cell-to-cell ER stress transmission by modulating membrane fluidity.. J Cell Biol 224(5) PMID: 40136051
- 2. Bollinger CR et al.. 2005. Ceramide-enriched membrane domains.. Biochim Biophys Acta 1746(3):284-94 PMID: 16226325
- 3. Spence MW. 1993. Sphingomyelinases.. Adv Lipid Res 26:3-23 PMID: 8379456
- 4. Kim Y et al.. 2026. Cholesterol depletion activates trafficking-coupled sphingolipid synthesis.. J Cell Biol 225(4) PMID: 41556882
- 5. Chatterjee S. 1993. Neutral sphingomyelinase.. Adv Lipid Res 26:25-48 PMID: 8379453
- 6. Kanemaru K et al.. 2026. Lipid balance and chemoresistance in cancer cells.. Elife 15 PMID: 41521896
- 7. Signorelli P et al.. 2021. The Multiple Roles of Sphingomyelin in Parkinson's Disease.. Biomolecules 11(9) PMID: 34572524
- 8. Slotte JP. 2013. Biological functions of sphingomyelins.. Prog Lipid Res 52(4):424-37 PMID: 23684760
